R35 GM140837/GM/NIGMS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2021	7
2022	5
2023	8
2024	0

1

Dihydropyridine Lactam Analogs Targeting BET Bromodomains.

Jiang J, Sigua LH, Chan A, Kalra P, Pomerantz WCK, Schönbrunn E, Qi J, Georg GI. Jiang J, et al. ChemMedChem. 2022 Jan 5;17(1):e202100407. doi: 10.1002/cmdc.202100407. Epub 2021 Dec 21. ChemMedChem. 2022. PMID: 34932262 Free PMC article.

2

Recent progress and structural analyses of domain-selective BET inhibitors.

Divakaran A, Harki DA, Pomerantz WCK. Divakaran A, et al. Med Res Rev. 2023 Jul;43(4):972-1018. doi: 10.1002/med.21942. Epub 2023 Mar 27. Med Res Rev. 2023. PMID: 36971240 Review.

3

¹⁹F NMR viewed through two different lenses: ligand-observed and protein-observed ¹⁹F NMR applications for fragment-based drug discovery.

Buchholz CR, Pomerantz WCK. Buchholz CR, et al. RSC Chem Biol. 2021 Jul 12;2(5):1312-1330. doi: 10.1039/d1cb00085c. eCollection 2021 Oct 7. RSC Chem Biol. 2021. PMID: 34704040 Free PMC article. Review.

4

Alternative Mechanisms for DNA Engagement by BET Bromodomain-Containing Proteins.

Kalra P, Zahid H, Ayoub A, Dou Y, Pomerantz WCK. Kalra P, et al. Biochemistry. 2022 Jul 5;61(13):1260-1272. doi: 10.1021/acs.biochem.2c00157. Epub 2022 Jun 24. Biochemistry. 2022. PMID: 35748495 Free PMC article.

5

Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader.

Divakaran A, Scholtz CR, Zahid H, Lin W, Griffith EC, Lee RE, Chen T, Harki DA, Pomerantz WCK. Divakaran A, et al. ACS Med Chem Lett. 2022 Sep 29;13(10):1621-1627. doi: 10.1021/acsmedchemlett.2c00300. eCollection 2022 Oct 13. ACS Med Chem Lett. 2022. PMID: 36262390 Free PMC article.

6

A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes.

Cui H, Divakaran A, Hoell ZJ, Ellingson MO, Scholtz CR, Zahid H, Johnson JA, Griffith EC, Gee CT, Lee AL, Khanal S, Shi K, Aihara H, Shah VH, Lee RE, Harki DA, Pomerantz WCK. Cui H, et al. J Med Chem. 2022 Feb 10;65(3):2342-2360. doi: 10.1021/acs.jmedchem.1c01779. Epub 2022 Jan 10. J Med Chem. 2022. PMID: 35007061 Free PMC article.

7

Soluble Methane Monooxygenase Component Interactions Monitored by ¹⁹F NMR.

Jones JC, Banerjee R, Shi K, Semonis MM, Aihara H, Pomerantz WCK, Lipscomb JD. Jones JC, et al. Biochemistry. 2021 Jun 29;60(25):1995-2010. doi: 10.1021/acs.biochem.1c00293. Epub 2021 Jun 8. Biochemistry. 2021. PMID: 34100595 Free PMC article.

8

4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity.

Cui H, Carlson AS, Schleiff MA, Divakaran A, Johnson JA, Buchholz CR, Zahid H, Vail NR, Shi K, Aihara H, Harki DA, Miller GP, Topczewski JJ, Pomerantz WCK. Cui H, et al. J Med Chem. 2021 Jul 22;64(14):10497-10511. doi: 10.1021/acs.jmedchem.1c00933. Epub 2021 Jul 8. J Med Chem. 2021. PMID: 34236185 Free PMC article.

9

Fluorous Liquids for Magnetic Resonance-Based Thermometry with Enhanced Responsiveness and Environmental Degradation.

Li J, Mundhenke TF, Smith TG, Arnold WA, Pomerantz WCK. Li J, et al. Anal Chem. 2023 Apr 11;95(14):6071-6079. doi: 10.1021/acs.analchem.3c00172. Epub 2023 Mar 31. Anal Chem. 2023. PMID: 37000984

10

Design of Class I/IV Bromodomain-Targeting Degraders for Chromatin Remodeling Complexes.

Zahid H, Costello JP, Li Y, Kimbrough JR, Actis M, Rankovic Z, Yan Q, Pomerantz WCK. Zahid H, et al. ACS Chem Biol. 2023 Jun 16;18(6):1278-1293. doi: 10.1021/acschembio.2c00902. Epub 2023 Jun 1. ACS Chem Biol. 2023. PMID: 37260298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year